NCT04060706Recruiting
Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy
Hamlet-RT: Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy
Source: ClinicalTrials.gov · Last updated 2 Aug 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Hamlet.rt study is a prospective data collection and patient questionnaire study for patients undergoing image-guided radiotherapy with curative intent. The aim of the study is to use novel machine learning and mathematical techniques to build a model that can predict the risk of significant side effects from radiotherapy treatment for an individual patient: using calculations of normal tissue dose from radiotherapy treatment planning and patient baseline characteristics derived from image and non-image data, continuously updated as the patient is reviewed both during and after treatment. A secondary goal of the project is to facilitate research in machine learning and medical image processing for radiation therapy through the creation of a discoverable and shared data resource for research use.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 310 (estimated)
- First submitted
- 15 Aug 2019
- Start date
- 11 Sept 2019
- Primary completion date
- 1 Jan 2023
- Lead sponsor
- CCTU- Cancer Theme
- NCT number
- NCT04060706
What you commit to
- Study type: Observational
- Planned participants: 310
- From 11 Sept 2019 to the primary completion date, 1 Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participant is not willing or able to complete the protocol-stated requirements of the study, e.g. accessing \& completing web-based long-term follow-up questionnaires.
Who the study is looking for
- Participant is willing and able to give informed consent for participation in the study
- Male or Female
- Aged 18 years or older
- Diagnosed with primary prostate cancer, head and neck cancer, lung cancer, or brain tumour
- Treated with curative intent
- Suitable for radical image guided radiotherapy
- WHO ECOG performance status 0 or 1
- Expected survival of 18 months or more
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cambridge University Hospitals NHS Foundation Trust Coordinator of this site? Confirm its status | Cambridge | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.